Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
- Status
- RECRUITING
- Phase
- PHASE2
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Preoperative Radiotherapy And ASTX660 in Rectum Cancer
- Status
- RECRUITING
- Phase
- PHASE1
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Adaptive Radiation in Anal Cancer
- Status
- RECRUITING
- Phase
- NA
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- Status
- RECRUITING
- Phase
- PHASE1
QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
- Status
- UNKNOWN
- Phase
- PHASE2
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
- Status
- RECRUITING
- Phase
- PHASE3
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2